Cargando…

Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers

The receptor activator of nuclear factor kappa B (RANK) is becoming recognized as a master regulator of tumorigenesis, yet its role in gynecological cancers remains mostly unexplored. We investigated whether there is a gradation of RANK protein and mRNA expression in epithelial ovarian cancer (EOC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez, Raul, Tejada, Miguel Á., Rodríguez-García, Víctor, Burgués, Octavio, Santos-Llamas, Ana I., Martínez-Massa, Andrea, Marín-Montes, Antonio, Tarín, Juan J., Cano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836022/ https://www.ncbi.nlm.nih.gov/pubmed/35163671 http://dx.doi.org/10.3390/ijms23031742

Ejemplares similares

Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level
por: Gómez, Raúl, et al.
Publicado: (2018)

A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment
por: Tejada, Miguel Á., et al.
Publicado: (2021)

Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women
por: Pertusa, Clara, et al.
Publicado: (2020)

Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation.
por: Homaidan, Fadia R, et al.
Publicado: (2003)

Attenuation of nuclear factor kappa B (NF-kappaB) promotes apoptosis of kidney epithelial cells: a potential mechanism of mercury-induced nephrotoxicity.
por: Woods, James S, et al.
Publicado: (2002)

Aurora kinases in ovarian cancer
por: Pérez-Fidalgo, J Alejandro, et al.
Publicado: (2020)

Nuclear factor-kappaB regulates the transcription of NADPH oxidase 1 in human alveolar epithelial cells
por: Wu, Weijing, et al.
Publicado: (2021)

BRCA mutation in high grade epithelial ovarian cancers
por: Manchana, Tarinee, et al.
Publicado: (2019)

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)

Role of nuclear factor-kappa B in bleomycin induced pulmonary fibrosis and the probable alleviating role of ginsenoside: histological, immunohistochemical, and biochemical study
por: El-Bassouny, Dalia Refaat, et al.
Publicado: (2021)

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis
por: Gunduz, Kamer, et al.
Publicado: (2012)

The dichotomy of inhibiting nuclear factor kappa-B in pneumonia
por: Abraham, Edward
Publicado: (2013)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
por: Miraghazadeh, Bahar, et al.
Publicado: (2018)

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
por: Murphy, Caitlin E., et al.
Publicado: (2021)

Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2023)

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
por: Chen, Ming, et al.
Publicado: (2014)

Dietary fat intake and risk of epithelial ovarian cancer by tumour histology
por: Merritt, M A, et al.
Publicado: (2014)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Computed Tomographic Radiomics in Differentiating Histologic Subtypes of Epithelial Ovarian Carcinoma
por: Wang, Mandi, et al.
Publicado: (2022)

PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
por: Shen, Hongwei, et al.
Publicado: (2021)

Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway
por: Xiao, Xue, et al.
Publicado: (2016)

Lipoproteins Are Potent Activators of Nuclear Factor Kappa B in Mammary Epithelial Cells and Virulence Factors in Mycoplasma bovis Mastitis
por: Schneider, Peleg, et al.
Publicado: (2022)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2016)

Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis: quantifying robustness using Cohen’s kappa
por: Daly, Caitlin H, et al.
Publicado: (2019)

Intraoperative Cytology of Ovarian Neoplasms with an Attempt to Grade Epithelial Tumors
por: Bohara, Sangita, et al.
Publicado: (2018)

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013)

Both reduced ovarian reserve and severe semen alterations are overrepresented in couples seeking assisted reproductive technology treatment for the first time: a cross-sectional study
por: Tarín, Juan J., et al.
Publicado: (2023)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
por: Zhang, Luodan, et al.
Publicado: (2022)

Recent insights into the role of NF-kappaB in ovarian carcinogenesis
por: Alvero, Ayesha B
Publicado: (2010)

Epithelial Ovarian Cancer and the Occurrence of Skin Cancer in The Netherlands: Histological Type Connotations
por: van Niekerk, Catharina C., et al.
Publicado: (2011)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
por: Earp, Madalene A, et al.
Publicado: (2017)

Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019)

Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis
por: Mæhle, B. O., et al.
Publicado: (1982)

Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia
por: Kurek, Krzysztof, et al.
Publicado: (2015)

Histological grading in carcinoma of the breast.
por: Wolff, B.
Publicado: (1966)

Histological grading in breast cancer.
por: Tough, I. C., et al.
Publicado: (1969)

The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer
por: Molnár, Szabolcs, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vc29bupskg9tchekkjn2t5jhlp